Journal of APPLIED BIOMEDICINE
ISSN 1214-0287 (on-line)
ISSN 1214-021X (printed)

Volume 3 (2005), No 2, p 59-66




Selenium and the prostate

Wilfred N. Arnold

Address: University of Kansas Medical Center, Kansas City, Kansas 66160-7421, USA
warnold@kumc.edu

Received 12th February 2005.
Revised 18th April 2005.
Published online 10th May 2005.

Full text article (pdf)

SUMMARY
Evidence accrued over the last decade has supported an association between low serum selenium (Se) and increased incidence of prostate cancer in older men. Accordingly, questions and inquiry arose as to whether a dietary supplementation might afford protection, or delay disease progression. Indeed, a very large national study, Selenium and Vitamin E Cancer Prevention Trial (SELECT), to explore the potential benefits of a daily supplement of 200 microgram Se, or 400 I.U. of vitamin E, or both, is underway: the National Cancer Institute anticipates a total enrolment of 32,400 men and durations of 7 to 12 years for individual participants. It is remarkable that at the time of the trial's activation in 2001 nothing was known about the concentration of Se in the target organ or whether any Se in a dietary supplement found its way to the prostate gland. Later, our laboratory published the first benchmark values, which indicated that the prostate is reasonably well endowed with Se and that the concentration in one subject, who had undergone self-medication at 200 microgram Se per day, was about twice the average for the others. This review explores the ramifications of these and subsequent data for SELECT and other trials, together with observations on dose and general mechanisms of Se interference with the development of prostate cancer.

KEY WORDS
selenium; prostate; cancer; supplementation trials


REFERENCES
Aaseth J, Smith-Kielland A, Thomassen Y: Selenium, alcohol and liver diseases. Ann Clin Res 18:43-47, 1986.

Arnold WN, Thrasher JB: Selenium concentration in the prostate. Biol Trace El Res 91:277-280, 2003.

Arthur JR, Nicol F, Grant E, Beckett GJ: The effects of selenium deficiency on hepatic type-I iodothyronine deiodinase and protein disulphide-isomerase assessed by activity measurements and affinity labeling. Biochem J 274:297-300, 1991.

Barry MJ: Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 344:1373-1377, 2001.

Beck MA: Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice. Biomed Environ Sci 10:307-315, 1997.

Beck MA, Kolbeck PC, Shi Q et al.: Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J Infect Dis 170:351-357, 1994.

Beck MA, Shi Q, Morris VC, Levander OA: Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1:433-436, 1995.

Brooks JD, Metter EJ, Chan DW et al.: Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166:2034-2038, 2001.

Clark LC, Cantor KP, Allaway WH: Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 46:37-42, 1991.

Clark LC, Combs Jr. GF, Turnbull BW et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 276:1957-1963, 1996.

Clark LC, Dalkin B, Krongrad A et al.: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730-734, 1998.

Duffield-Lillico AJ, Dalkin BL, Reid ME et al.: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91:608-612, 2003.

Epp O, Ladenstein R, Wendel A: The refined structure of the selenoenzyme glutathione peroxidase at 0.2 nm resolution. Eur J Biochem 133:51-69, 1983.

Ge K, Yang G: The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 57:259-263, 1993.

Gianduzzo TR, Holmes EG, Tinggi U et al.: Prostatic and peripheral blood selenium levels after oral supplementation. J Urol 170:870-873, 2003.

Gohagan JK, Prorok PC, Kramer BS, Cornett JE: Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol 152:1905-1909, 1994.

Guilbert LJ, Iscoe NN: Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature 263:594-595, 1976.

Hartman TJ, Taylor PR, Alfthan G et al.: Toenail selenium concentration and lung cancer in male smokers (Finland). Cancer Causes Control 13:923-928, 2002.

Hill KE, McCollum GW, Boeglin ME, Burk RF: Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 234:293-295, 1997.

Holmberg L, Bill-Axelson A, Helgesen F et al.: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347:781-789, 2002.

Hoque A, Albanes D, Lippman SM et al.: Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 12:627-633, 2001.

Jensen R, Closson W, Rothenberg R: Epidemiologic notes and reports: selenium intoxication New York. MMWR CDC Surveill Summ 33:157-158, 1984. [see also, JAMA 251:1938, 1984.]

Kim SP, Bennett CL, Chan C et al.: QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Huntingt.) 13:823-832, 1999.

Klein EA, Thompson IM, Lippman SM et al.: SELECT: The selenium and vitamin E cancer prevention trial: rationale and design. Prostate Cancer Prostatic Dis 3:145-151, 2000.

Levander OA: Metabolic interrelationships and adaptations in selenium toxicity. Ann NY Acad Sci 192:181-192, 1972.

Levander OA: A global view of human selenium nutrition. Annu Rev Nutr 7:227-250, 1987.

Levander OA, Alfthan G, Arvilommi H et al.: Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am J Clin Nutr 37:887-897, 1983.

Lombeck I, Kasperek K, Feinendegen LE, Bremer HJ: Serum-selenium concentrations in patients with maple-syrup-urine disease and phenylketonuria under diet-therapy. Clin Chim Acta 64:57-61, 1975.

Lyon TD, Fell GS, Halls DJ, Clark J, McKenna F: Determination of nine inorganic elements in human autopsy tissue. J Trace Elem Electrolytes Health Dis 3:109-118, 1989.

McKeehan WL, Hamilton WG, Ham RG: Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts. Proc Natl Acad Sci USA 73:2023-2027, 1976.

Medinsky MA, Cuddihy RG, Griffith WC, McClellan RO: A stimulation model describing the metabolism of inhaled and ingested selenium compounds. Toxicol Appl Pharmacol 59:54-63, 1981.

Moreno-Reyes R, Suetens C, Mathieu F et al.: Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 339:1112-1120, 1998.

Moyad MA: Selenium and vitamin E supplements for prostate cancer: evidence or embellishment? Urology 59 (4, suppl. 1):9-19, 2002.

Patterson EL, Milstrey R, Stokstad ELR: Effect of selenium in preventing exudative diathesis in chicks. Proc Soc Exptl Biol Med 95:617-620, 1957.

Pohl B, Schneider T: Determination of Normal Levels of Selenium in Blood Serum by GFAAS. Varian Optical Spectroscopy Instruments, Instruments at work, AA-103, August 1991.

Raich PC, Lu J, Thompson HJ, Combs GF: Selenium in cancer prevention: clinical issues and implications. Cancer Invest 19:540-553, 2001.

Rotruck JT, Pope AL, Ganther HE et al.: Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588-590, 1973.

Salonen JT, Huttunen JK: Selenium in cardiovascular diseases. Ann Clin Res 18:30-35, 1986.

Schaller KH, Schiele R: Selenium. In Alessio L, Berlin A, Roi R (eds): Biological Indicators for the Assessment of Human Exposure to Industrial Chemicals, Comm Eur Commun Luxembourg 1989, pp. 77-93.

Schwarz K, Foltz CM: Selenium as an integral part of Factor 3 against dietary necrotic liver degeneration. J Amer Chem Soc.71:3292-3293,1957.

Schwarz K, Bieri JG, Briggs GM, Scott ML: Prevention of exudative diathesis in chicks by Factor 3 and selenium. Proc Soc Exptl Biol Med 95:621-625, 1957.

Shamberger RJ, Frost DV: Possible protective effect of selenium against human cancer. Can Med Assoc J 104:82-84, 1968.

Sheehan TMT, Halls DJ: Measurement of selenium in clinical specimens. Ann Clin Biochem 36:301-315, 1999.

Stadtman TC: Specific occurrence of selenium in enzymes and amino acid tRNAs. Faseb J 1:375-379, 1987.

Stadtman TC: Biosynthesis and function of selenocysteine-containing enzymes. J Biol Chem 266:16257-16260, 1992.

Stratton MS, Reid ME, Schwartzberg G et al.: Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study. Anticancer Drugs 14:589-594, 2003a.

Stratton MS, Reid ME, Schwartzberg G et al.: Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study. Anticancer Drugs 14:595-600, 2003b.

Sunde RA: Selenium. In O'Dell BL and Sunde RA (eds): Handbook of Nutritionally Essential Minerals, Marcel Dekker, New York 1997, pp. 493-556.

Thompson IM, Pauler DK, Goodman PJ et al.: Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 350:2239-2246, 2004.

Vanderpas JB, Contempre B, Duale NL et al.: Iodine and selenium deficiency associated with cretinism in northern Zaire. Am J Clin Nutr 52:1087-1093, 1990.

Willett WC, Polk BF, Morris JS et al.: Prediagnostic serum selenium and risk of cancer. Lancet 2:130-134, 1983.

Wilt TJ, Brawer MK: The prostate cancer intervention versus observation trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 152:1903-1904, 1994.

Yang G, Zhou R: Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J Trace Elem Electrolytes Health Dis 8:159-165, 1994.

Yang G, Wang S, Zhou R, Sun S: Endemic selenium intoxication of humans in China. Am J Clin Nutr 37:872-881, 1983.

Yoshizawa K, Willett WC, Morris SJ et al.: Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90:1219-1224, 1998.
CITED

Zaichick S, Zaichick V. Trace elements of normal, benign hypertrophic and cancerous tissues of the Human prostate gland investigated by neutron activation analysis. Appl Radiat Isot. 70: 81-87, 2012.

Gupta UC, Gupta SC. Selenium deficiency in soils and crops and its impact on animal and human health. Curr Nutr Food Sci. 6: 268-280, 2010.

BACK